Gene · 11213
Papers1,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of two robust subclasses of sepsis with both prognostic and therapeutic values based on machine learning analysis. | Front Immunol | 2022 | 36505503 | PubTator, text mining | PubMed |
| Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence. | Molecules | 2022 | 36500540 | PubTator, text mining | PubMed |
| SARS-CoV-2-Associated ssRNAs Activate Human Neutrophils in a TLR8-Dependent Fashion. | Cells | 2022 | 36497044 | PubTator, text mining | PubMed |
| Hypoxia as a Double-Edged Sword to Combat Obesity and Comorbidities. | Cells | 2022 | 36496995 | PubTator, text mining | PubMed |
| Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitis. | Commun Biol | 2022 | 36482174 | PubTator, text mining | PubMed |
| Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. | Biomark Res | 2022 | 36476317 | PubTator, text mining | PubMed |
| Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls. | Front Immunol | 2022 | 36466858 | PubTator, text mining | PubMed |
| DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma. | BMC Immunol | 2022 | 36451087 | PubTator, text mining | PubMed |
| Analysis of signature genes and association with immune cells infiltration in pediatric septic shock. | Front Immunol | 2022 | 36439140 | PubTator, text mining | PubMed |
| Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage. | Front Pharmacol | 2022 | 36438795 | PubTator, text mining | PubMed |
| Effects of Klebsiella pneumoniae Bacteriophages on IRAK3 Knockdown/Knockout THP-1 Monocyte Cell Lines. | Viruses | 2022 | 36423191 | PubTator, text mining | PubMed |
| Screening of ulcerative colitis biomarkers and potential pathways based on weighted gene co-expression network, machine learning and ceRNA hypothesis. | Hereditas | 2022 | 36419192 | PubTator, text mining | PubMed |
| Biomarkers of sequela in adult patients convalescing from COVID-19. | Adv Biomark Sci Technol | 2022 | 36404876 | PubTator, text mining | PubMed |
| Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes. | Respir Res | 2022 | 36403043 | PubTator, text mining | PubMed |
| Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis. | World J Surg Oncol | 2022 | 36397165 | PubTator, text mining | PubMed |
| microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. | Front Cell Infect Microbiol | 2022 | 36389170 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
| Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells. | Front Immunol | 2022 | 36341352 | PubTator, text mining | PubMed |
| The Interplay of Oxidative Stress and ROS Scavenging: Antioxidants as a Therapeutic Potential in Sepsis. | Vaccines (Basel) | 2022 | 36298439 | PubTator, text mining | PubMed |
| Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends. | Cancers (Basel) | 2022 | 36291803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11213/papers?page=11